The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Platelet counts (PLT) at baseline and on treatment as predictor for progression free survival (PFS) in patients with advanced malignant pleural mesothelioma (MPM): EORTC 08052 study.
Rabab Mohamed Gaafar
No relevant relationships to disclose
Sanjay Popat
No relevant relationships to disclose
Jan P. Van Meerbeeck
No relevant relationships to disclose
Paul Baas
Research Funding - Pfizer
Dean Fennell
No relevant relationships to disclose
Athanasios G. Pallis
No relevant relationships to disclose
Baktiar Hasan
No relevant relationships to disclose
Mary O'Brien
No relevant relationships to disclose